Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 16984392 | HLA-CLASS I (HLA-I) | follicular lymphoma | NA | NA | NA | unclassified | |
| this study developed an appropriate, autologous follicular b-cell non-hodgkin follicular lymphoma model, including the in vitro establishment of a malignant, human leucocyte antigen class i (hla-i) deficient b-cell line, and the generation of three autologous anti-tumour cytotoxic cd4(+) t-cell clones originating from the peripheral blood of the same patient. | |||||||
| 21133715 | HLA-DQB1 (HLA-DQB1) | follicular lymphoma | NA | NA | NA | unclassified | |
| association of hla-dqb1 alleles with risk of follicular lymphoma. | |||||||
| 21133715 | HLA-DQB1*05 | follicular lymphoma | NA | NA | NA | only_studied | |
| in a recent genome-wide association study of follicular lymphoma (fl), we identified novel risk alleles on chromosome 6p21.33 that appeared to be part of an extended haplotype including hla-drb1*0101, dqa1*0101, and dqb1*0501. | |||||||
| 21133715 | HLA-DQA1*01 | follicular lymphoma | NA | NA | NA | only_studied | |
| in a recent genome-wide association study of follicular lymphoma (fl), we identified novel risk alleles on chromosome 6p21.33 that appeared to be part of an extended haplotype including hla-drb1*0101, dqa1*0101, and dqb1*0501. | |||||||
| 21133715 | HLA-DRB1*01 | follicular lymphoma | NA | NA | NA | only_studied | |
| in a recent genome-wide association study of follicular lymphoma (fl), we identified novel risk alleles on chromosome 6p21.33 that appeared to be part of an extended haplotype including hla-drb1*0101, dqa1*0101, and dqb1*0501. | |||||||
| 21233317 | HLA (HLA) | NA | NA | rs10484561 | rs6457327 | unclassified | |
| NA | |||||||
| 21233317 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | NA | NA | rs10484561 | rs6457327 | only_studied | |
| NA | |||||||
| 25279986 | HLA (HLA) | rs4937362 | European | rs6444305 | rs4938573 | only_studied | |
| Lymphoma, Non-Hodgkin | |||||||
| 25279986 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | rs4937362 | European | rs6444305 | rs4938573 | only_studied | |
| Lymphoma, Non-Hodgkin | |||||||
| 31494742 | HLA-A*02 | follicular lymphoma | NA | NA | NA | unclassified | |
| based on in vitro binding assays to recombinant human mhc ii molecules and on in vivo immunization assays in h-2 ko/hla-a2+-dr1+ transgenic mice, we have identified 21 mhc ii-restricted long peptides derived from intracellular, membrane, or extracellular domains of the human non-mutated cd20 protein that trigger in vitro ifn-g production by pbmcs and splenocytes from healthy individuals and by pbmcs from follicular lymphoma patients. | |||||||
Copyright 2024